Forbes August 3, 2023
Topline
The FDA and CDC have approved the first RSV vaccines for infants and seniors, and are expected to make a decision on other RSV vaccine approval by the fall in anticipation for the winter—here are some of the top contenders that have shown promising signs in trials.
Key Facts
News Peg
Nirsevimab, Sanofi and AstraZeneca’s RSV vaccine for infants received unanimous backing from an advisory committee to the CDC on August 3. This comes almost two months after an FDA advisory committee unanimously recommended the shot. A Sanofi spokesperson told NBC News the company was ready to release the vaccine before RSV season this fall.
Surprising Fact
Almost all children will have had an RSV infection by their second...
Today's Sponsors
Today's Sponsor